United States: DC Metro Area

Firms: litigation

Firms: prosecution

Firms: transactions

Adduci, Mastriani & Schaumberg, LLP

Adduci, Mastriani & Schaumberg knows the International Trade Commission (ITC) better than just about any firm, making it a hot commodity in the patent litigation market. For insight on rules, procedures, judges and more – as well as first-class representation – name partners James Adduci, Tom Schaumberg and Louis Mastriani are the ones to call.

Akin Gump Strauss Hauer & Feld LLP

In October 2019 Akin Gump unveiled new signing Andrew Holtman, who joined by way of Finnegan. He has significantly amped up the firm’s post-grant practice, as a veteran of 50-plus inter partes reviews. He joins former supercomputer designer turned elite trial lawyer Cono Carrano and ITC specialist David Vondle, resulting in a group that can handle itself adroitly in any forum. For clients like VIZIO, this is a blessing: Carrano and Vondle recently obtained for it a complete ITC victory against Broadcom, having stayed a Central District of California case they were litigating between the two parties; they also successfully filed inter partes review petitions which were terminated following the ITC ruling.

Arnold & Porter Kaye Scholer LLP

“You have to tip your hat to Arnold & Porter for its high-quality, effective lawyering in big patent litigations.” DC trial supremo Matthew Wolf has been spurring on the firm to great success in some of the highest-profile cases going – his major win for Boston Scientific against Edwards Lifesciences being a prime example. In this global dispute involving transcatheter heart valve replacement therapy, Wolf served as lead trial counsel and strategy head of the global team, with responsibility for ensuring careful cross-border coordination – roles he played with rigour and precision. “Calm, smart and a brilliant leader, Wolf is one of the most skilled trial lawyers anywhere. The resonance of his oral advocacy puts him at the top of the list.” Wolf has also been going gangbusters for Google and Hologic lately. Another best-in-class lawyer in DC is David Marsh, who helms the prosecution practice. He carries out important work for Bayer in the area of plant genetics and provides essential strategic counsel to Bruin Biometrics in the medical device field. The distinguished Brit (who is a member of the Order of the British Empire) “takes the time to thoroughly understand your business and technology and tailors his service to meet your needs with exactitude”. “He has assembled a talented team around him and represents excellent value for money.” Testament to its versatility, Arnold & Porter has representatives on each of the litigation, prosecution and transactions tables. Co-captain of the technology and life sciences transactions practice Susan Hendrickson has negotiated a dizzying variety of commercial partnering deals over her 25-year career.

Baker Botts LLP

The patent practice at Baker Botts in DC is percolating nicely. In prosecution, the team is now engaged with Broadcom, having served predecessor CA Technologies for many years, and continues to thrive representing Japanese entities such as Brother Industries. On the deal side, the group is increasingly busy for private equity players, such as American Industrial Partners; and has also carried out some major complex licensing for a leading construction equipment manufacturer. At the forefront of all this is the multi-talented Luke Pedersen, who chairs the technology transactions group. Another versatile counsellor to note is Michael Sartori, who has settled in nicely following his move from Venable at the start of 2019. He is superb at managing large portfolios and contributes much by way of technical expertise in litigation. The litigation picture is rosy, too – particularly when looked at through an ITC filter. Lisa Kattan, who has deep experience in some of the more exotic import-related proceedings, is an ace up the firm’s sleeve for Section 337 investigations. With Kattan playing a central role, Baker Botts recently settled global litigation for Fujifilm against Sony, having won three ITC trials and two proceedings before US Customs and Border Protection.


BakerHostetler is a reliable guide throughout all phases of the patent lifecycle. Many of its 170 IP lawyers maintain multifaceted practices and, as a result, can meaningfully support clients’ business development in different ways. Prime examples in the DC line-up include Kenneth Sheehan, cited by one patron as “easily among the elite patent attorneys in the country”. “He has a deep knowledge of IP law and does a variety of patent work, from freedom-to-operate counselling to prosecution and litigation.” Robert Hails also confidently crosses the contentious/non-contentious divide. He prosecutes patents for Apple in the graphics and video coding space and litigates across many forums and has recently been in action at the ITC in a do-or-die case for Jubliant Life Sciences and subsidiaries, against which allegations of infringement of state-of-the-art heart imaging patents have been levelled. Alongside him on this is Cy Walker, a veteran ITC campaigner. “Robert and Cy are not scorched-earth litigators – they do a great job as practical and professional operators.” There are those more specialised in the DC line-up, too: IAM Patent 1000 newcomer Hussein Akhavannik co-leads the life sciences team and concentrates on prosecution and portfolio management. “Hussein thinks outside the box and adapts his team well in light of changing client demands. He runs prosecution efficiently while also doing really high-quality work.” William Bergmann is a litigator who makes regular appearances in the Court of Federal Claims on issues relating to government contracts.

Banner Witcoff

There are a lot of lifers at Banner Witcoff. It’s an excellent home for a wide variety of practitioners, including business development go-getters and professionals with commitments outside the law; this gives it a diversity and vibrancy that make people want to stay. Clients certainly appreciate the stability of having the same lawyers on hand as they travel on their innovation and business journeys – individuals such as Ross Dannenberg, who has been here for 19 years and counting. Dannenberg is having a lot of fun in the practice right now because of the variety of matters landing on his desk; he has also carved a niche in the videogame world, which ties into one of his interests away from the office. Bringing energy and enthusiasm to every engagement, the computer science ace handles a significant proportion of Citrix Systems’ prosecution matters – and has done so for a decade – and also acts for unicorn Improbable Worlds in the gaming space. Robert Katz and Darrell Mottley are also doing what they love: running a market-leading designs practice that is the go-to for marquee companies such as Nike and Microsoft. In litigation, John Hutchins is enjoying his time here following a move from Hunton Andrews Kurth in 2018. There’s no drama or distraction around him, allowing him to devote his mind to the complex litigation and PTAB work he does best. He and Frederic Meeker form the core of the firm’s punchy post-grant practice and have been connecting on inter partes reviews for Comcast – a relationship that Meeker has led on for a long time.

Birch, Stewart, Kolasch & Birch, LLP

When it comes to successful patenting, BSKB is one of the best to partner with. It obtains thousands of patents per year, in the course of which it harvests valuable data about the USPTO and its performance, which is fed through into further procurement efforts in a virtuous circle. The boutique stands out for its efficiency and sophistication in prosecution.

Bookoff McAndrews PLLC

Looking back at the past 18 months, growth is the clear theme at this patent boutique. Existing patrons are giving instructions in greater volumes, while new clients are coming on board; new attorneys have joined too, giving an already inclusive team an even more diverse look. This healthy dynamic is reflected in the sheer quality of work being produced. The set is driven by a powerful desire to master patent procurement and portfolio management, and provide the best counsel going. Sharing these motivations are Dinesh Melwani and Kirsten Johnson, both of whom pick up great feedback. “Dinesh understands the benefits of a cohesive team in which individuals support each other and are free of ego. A real champion of diversity, he empowers every voice and does his utmost to ensure everyone feels valued. He understands business and gives thoughtful, practical counsel to help you make crucial decisions. He also always comes prepared and knows what questions to ask to encourage productive conversations.” “Kirsten’s legal and technical expertise and analytical skills are readily apparent from her advice and top-notch product. She is gifted at grasping even the most complex ideas and turning them into straightforward patent claims.” Also enthusiastically endorsed, Roland McAndrews “has a USPTO background that is invaluable in generating claim wording that examiners will approve of. Accounting for your commercial needs, he gives frank and honest answers and personal attention to matters.” He sets the tone of excellence alongside fellow medical device guru Les Bookoff, with whom he works assiduously for Boston Scientific Corporation – a client that Melwani and Johnson also support – on worldwide patent management. Another of Bookoff’s patrons is HeartFlow, a global pioneer in using coronary CT scans and computational fluid dynamics to simulate and analyse patient-specific coronary blood flow, whose complex technology and innovations he protects. With him on this is Christopher Agrawal, who runs a burgeoning computer and internet practice.

Buchanan Ingersoll & Rooney PC

A major recent initiative at Buchanan has been the creation of four industry groups – healthcare, energy, life sciences and finance – which sit above its highly specialised practice units, intellectual property among them. The move has facilitated the freer flow of ideas between different practice teams operating in the same sector and, more specifically, has enhanced the synergies between the firm’s corporate, IP and regulatory groups. What this all means for clients is a more complete service, which is what executive shareholder Patrick Keane is all about. Keane is not someone who can be easily pigeonholed as, for example, an IP transactions lawyer; he is extremely broadminded, with an intuitive sense of the direction in which the global technology, business and legal markets are travelling.  Putting the IP section more squarely in the spotlight reveals a refined patent practice that is rich in procurement, post-grant and litigation expertise. Responsible for nearly 7,000 utility, plant and design patent applications at any time, Buchanan has certainly proved itself in prosecution. Over 45 USPTO registered practitioners man the ropes, many of whom are former examiners –including Matthew Fedowitz and Charles Wieland III. The former is a life sciences and medical device sage who also worked at the Food and Drug Administration (FDA); the latter a software maven with a leading blockchain practice. Other non-contentious names to note on this deep squad are prosecution co-chair William Rowland, who puts the emphasis on mechanical and electrical technologies; and chemical expert Robert Mukai. Recent years have seen Buchanan’s litigation offering evolve significantly. Fedowitz, named above, has helped to drive an uptick in pharmaceutical cases, as has litigation co-chair Lloyd Smith. The firm’s contentious appeal rests in no small measure on its facility for post-grant proceedings. Todd Walters made an easy transition to inter partes reviews, having handled many interferences over a long period.

Carmichael IP PLLC

Established by former PTAB administrative patent judges, Carmichael IP is uniquely positioned as a highly specialised prosecution and post-grant proceedings shop. James Carmichael spent eight years at the USPTO serving in different roles, including chief examiner of the electrical and computer division and Board of Appeals and Interferences and then PTAB judge; he is thus as good a guide as they come to the agency and its workings. In November 2019, the boutique brought former Goodwin Procter lawyer Stephen Schreiner – a long-time inductee in the IAM Patent 1000 – into the fold. Schreiner’s expertise encompasses the full patent lifecycle, making him an invaluable asset.

Cooley LLP

“Cooley’s growth in recent years has been impressive to see. The firm has branded itself extremely well in the technology transactions space.” One of the anchors of its dynamic deal practice on the East Coast is Adam Ruttenberg, whose work often has a transformative effect on the software, computing, internet and new media landscapes. Molecular biology PhD Michael Tuscan finds new paths forward for biotechnology innovators; the versatile operator designs market exclusivity strategies and prosecutes and commercialises patent rights. Well-roundedness emerges as the watchword when assessing Cooley’s practice. Erik Milch is another do-it-all guy, as a strong litigator with prosecution, counselling and licensing experience. In disputes, “he clearly does his homework and takes an analytic, factual approach”. Sources further describe his demeanour as “very even keeled”. In his preferred domains of medical technology, aerospace and energy, Scott Talbot renders holistic solutions to patent problems having practiced in all areas. Frank Pietrantonio’s clever tactics in litigation are inspired by everything that he has seen as a counsellor. The firm was recently joined by former Finnegan lawyer Sanya Sukduang, an esteemed pharmaceutical patent litigator and strategic counsellor.

Covington & Burling LLP

Reclaiming its IAM Patent 1000 DC Metro Area gold-tier ranking this year, Covington & Burling is an elite contentious performer, with one of the deepest patent trial benches in the capital. Its IP lawyers also have a market-leading regulatory practice to call on for support, giving them a real edge in pharmaceutical patent litigation. The life sciences sector is a happy hunting ground for seasoned Hatch-Waxman Act litigators Einar Stole – a biochemistry PhD who stands out for his technical prowess – and Christopher Sipes, who brings deep regulatory knowledge to the mix. Resources for high-tech cases are abundant, too. Dean of the patent litigation bar George Pappas, former GE global IP litigation chief Richard Rainey and 45-trial veteran Kevin Collins can all be called on in complete confidence. There is a buzz about the firm’s ITC practice right now, as Sturgis Sobin has “made Covington a real force at the Commission”. “Sturge has had a terrific year. He never phones it in, but knows his cases back to front and is always available, which is so rare for someone at his level.” He is backed up by accomplished trade litigator Alexander Chinoy. Again benefiting from its synergistic FDA practice, the firm is “super-deep in life sciences transactions”. Co-chair of the cross-disciplinary life sciences group John Hurvitz is a new-deal-type architect for the pharmaceutical and biotechnology industries. Overseeing collaborations around internet, content creation and videogame technology, meanwhile, is Stuart Irvin.


As a leading global outfit, Dentons has an amazingly diverse client catalogue, which includes marquee international technology and life sciences companies. Instructed on all manner of patent matters, the firm has cultivated a 360-degree practice to meet whatever needs arise. Instrumental in this regard is the leadership of global IP chair Song Jung, based in DC. He has done not just a little, but a lot of everything in patent law and understands how different patent tasks feed into the satisfaction of long-range commercial goals. His foundational procurement and counselling skills are extremely strong, which is why LG Electronics keeps him on speed dial. At any given time, Jung and prosecution specialist Mark Kresloff are handling 4,000-plus patent matters for the Korean company, with which they enjoy a longstanding relationship. Martin Bruehs performs a similar role for chemicals and life sciences patrons, directing traffic with respect to international portfolios and guiding strategy. Mark Hogge is the top litigator on deck. With Jung, he is currently litigating two high-profile cases for LG Chem against lithium ion battery competitor SK Innovation – one in the ITC and the other in the District of Delaware.

Faegre Drinker Biddle & Reath LLP

Faegre Drinker is a new Am Law 50 outfit created following the February 2020 merger of Faegre Baker Daniels and Drinker Biddle & Reath. The firm has a richly resourced patent department, two of the best assets of which are located in DC: Mercedes Meyer and Robert Stoll. Meyer is a dynamic force for good in the biotech space and an exceptional patent protector and strategist who is “extremely well regarded”. As a former USPTO patent commissioner, Stoll can provide a unique level of insight to any company looking to get patents granted and protected through the post-grant process.

Fiala & Weaver PLLC 

Fiala & Weaver’s distributed structure – it has attorneys across the United States – is creating an advantage for it in the recruitment market; the search for talent is a competitive one, but being geographically unrestricted, it can draw from a larger and, crucially, more diverse pool. The advantage is an important one given the level of demand the firm is seeing from existing as well as new clients. The set makes light work of complex technologies and high-volume prosecution by using the right people and tools which creates room for directors Thomas Fiala and Jeffrey S Weaver to concentrate on the portfolio building, counselling and opinion giving they do best. Software is one of the group’s technical strong suits.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP 

Testament to its incredible depth in all areas of patent practice, Finnegan has the highest count of litigators (13), the joint-highest number of prosecutors (seven) and the second-largest team of transactional IP lawyers (three) in the IAM Patent 1000 DC Metro rankings for 2020. It also has multiple representatives on the US national tables covering appellate and ITC litigation, design patents and post-grant proceedings, which underscores both the depth and the sheer quality of its operation. The first-class boutique has grown and developed on all fronts this year: it added six attorneys to the partnership ranks with various litigation and USPTO-centred practices; expanded its agile, multidisciplinary industry and technology working groups, focused on fields as distinct as cosmetics and augmented reality; and accelerated its promotion of a diverse, inclusive culture. On the latter point, Finnegan is already a diversity leader not just in intellectual property, but in the legal and professional services market more broadly, giving it a vibrancy that really resonates with clients. In such a mature environment, lawyers disposed to sophisticated all-round counselling naturally thrive. Playing the trusted adviser role to perfection are Adriana Burgy, Gregory Gramenopoulos, Jeffrey Berkowitz and Mark Sweet. A sought-after opinion giver, Burgy demonstrates a mastery of both complex chemical and life sciences technology and patent strategy. In software, electronics and other high-technology spaces, Gramenopoulos distinguishes himself as a holistic global problem solver: he has prosecuted extensively, built valuable portfolios and advised lucidly on the most challenging infringement scenarios. “Greg is exceptionally well qualified and a consummate professional who stands out for his reasonableness and integrity. It is a privilege to work with him,” enthuse clients. Recent mandates include acting for Google with respect to design patent coverage for its graphical user interfaces and icons – a brief he handles alongside Elizabeth Ferrill, one of the foremost design patent protectors and litigators in the country. Berkowitz marries precision drafting skills with abundant experience in all facets of patent litigation. Chairman and managing partner of the firm, Sweet is in hot demand for high-level strategic oversight. He also makes a vital contribution to the side’s booming post-grant practice. In Erika Harmon Arner and Thomas Irving, Finnegan has two talismanic practitioners who have driven the development of America Invents Act proceedings since they were first introduced. Coming in for special praise, Irving has “done a lot of cool things in post-grant” and is “someone you look to for creative ideas”. Another jewel in the crown of the contentious division is the life sciences patent litigation offering spearheaded by Charles Lipsey, who is currently representing AstraZeneca in Hatch-Waxman Act litigation involving patents covering billion-dollar diabetes drug FARXIGA. “Charles is phenomenal – he is really smart on the science, hugely experienced and has a nice style in court.” He is surrounded by other immensely talented people, including seasoned lead counsel James Monroe; 360-degree patent lawyer Bryan Diner; district court litigation, PTAB proceedings and appellate ace Michael Flibbert; and trial veteran and chemistry PhD Barbara Rudolph, who is deemed a great choice for the most sensitive matters. Shining across all forums, Finnegan’s litigation team has been running hot and heavy at the ITC of late – for example, handling massive investigations on behalf of Toyota, against which Intellectual Ventures II filed a complaint. Driving hard on this matter and deftly handling the extensive coordination with multiple other respondents it requires are James Barney, Mareesa Frederick and Smith Brittingham, among others. One Section 337 regular says: “James and Mareesa are responsive, professional and knowledgeable about the Commission, and willing and able to work through all of the complexities of representing non-US companies in what is a very fast-paced forum.” The same is true of Qingyu Yin, whose sterling representation of Chinese entities at the ITC nets him a first appearance in the IAM Patent 1000 for 2020. Yin is also on hand for colleagues as they represent Chinese companies and recently teamed up with transactions pro Brian Kacedon on a patent pool licensing engagement. “Qingyu and Brian are good listeners with an exact understanding of their clients’ needs. They resolve problems in a timely fashion and are experienced lawyers who you always learn something from.” Another Chinese speaker is electrical engineering PhD Yanbin Xu, who litigates and prosecutes with poise. Providing exceptional leadership to a celebrated appellate practice, meanwhile, are Michael Jakes and former Federal Circuit clerk Doris Johnson Hines. Companies doing deals and embarking on exciting collaborations also find advanced professionals to rely on: recommended alongside Kacedon on the transactions table are licensing mavens John Paul and William Pratt.

Fisch Sigler LLP

Fundamental trial and appellate skill combined with a nimble approach gives Fisch Sigler its competitive bite in the legal market. Under virtually any circumstance and in any forum, Alan Fisch and his cohorts can pull out a win; and not just any win – the team judges itself by the success with which it supports clients’ commercial endeavours. Its victories, then, take many forms, including favourable jury verdicts, summary judgments and instant dismissals. Charismatic Alan Fisch, as well as being a brilliant courtroom lawyer, always has insightful input on legal and IP market trajectories, technology industry developments and myriad other topics.

Fish & Richardson

“Fish is among the very best when it comes to US patent litigation. It has a deep bench of experienced attorneys to draw on and is excellent at bringing on new talent.” Looked at through an ITC lens, the power of the litigation practice comes into sharp focus; with Ruffin Cordell and Michael McKeon on deck, the firm is perfectly poised to win the most hotly contested, commercially consequential and complex ITC cases. “Unbelievably good on his feet in court,” Cordell “draws good analogies and is a likeable person who connects well with judges and juries on a personal level and builds credibility”. He and “reasonable and genuine guy” McKeon pace the field, though Joseph Colaianni is not far behind; he is steeped in Section 337 practice and can run a case from start to finish in the most efficient, well-organised and tactically smart manner. All three litigate flawlessly in district courts, too. Cordell and McKeon – alongside other DC lawyers, including trial veteran Indranil Mukerji – are instructed on Samsung’s toughest cases wherever they arise; in a recent Eastern District of Texas action against SEVEN Networks regarding smartphone patents, the team took global discovery and developed cast-iron defences, causing SEVEN to drop multiple claims and patents from the suit before eventually settling out. Colaianni recently took the reins on a sizeable 13-patent Delaware case in which client MediaTek’s systems-on-chip products have been challenged by Dynamic Data. Other lead counsel types include Christian Chu, Ahmed Davis and Lauren Degnan. Chu is a “top-level litigator and tough adversary who nonetheless litigates in a respectful way”. Peers acknowledge Davis’s rise in the practice, saying: “He’s really developed and stepped up into first chair roles very effectively.” Degnan effortlessly handles suits impacting on entire industries and is noted for her appellate expertise. The litigation practice is strengthened immeasurably by Fish’s post-grant brilliance, central to which is Karl Renner, a lawyer who “speaks with authority” in front of administrative patent judges and in PTAB-focused professional organisations. To great effect, he frequently links up with Thomas Rozylowicz, who practises from a position of awesome technical strength in the software, electronics and communications fields. Another established post-grant leader is Timothy Riffe, who has made some 150 PTAB appearances; he’s also a dab ITC hand and has recently been representing NEC Corporation in an investigation relating to submarine fibre-optic data transmission cables alongside McKeon. A rising star of the post-grant practice, meanwhile, is David Holt, who is far more advanced in terms of lead counsel experience than his peers. The prosecution unit has had a tremendous year under the direction and leadership of patent group head John Hayden; an increase in demand among life sciences entities for its counselling and portfolio development dexterity is a notable development, as is growth in China following the February 2019 opening of a representative office in Shenzhen. Hayden keeps the side at the cutting edge; for example, he hears the drumbeat of AI and has pooled expertise in the area while also thinking carefully about the incorporation of AI tools within the firm’s practice. As with litigation, there is no shortage of stars in the prosecution division: “David Jordan has great portfolio development fundamentals and, because he understands the software landscape, provides spot-on counsel.” He does important work for Google. A rock for Fish for over 25 years, Phyllis Kristal is the go-to for mechanical engineering briefs.

Foley & Lardner LLP

Presenting a well-balanced, end-to-end service, Foley & Lardner is a smart-thinking choice for one-stop patent shopping. Helping the cross-disciplinary practice to function harmoniously are versatile practitioners such as Stephen Maebius, who has led trial, post-grant, deal, counselling and prosecution teams. He never looks at a lawsuit, transaction or portfolio in isolation, but always thinks about the bigger commercial picture while harnessing the resources around him effectively to help achieve clients’ goals. Active in diverse technical fields, he is particularly well versed in the life sciences. Michele Simkin and Courtenay Brinckerhoff also know the industry well. Like Maebius – with whom she shares a common background, having served as an examiner in the USPTO’s biotechnology group – Simkin plays an important strategic counselling role, thanks to her breadth of experience across portfolio management and transactions. So too does Brinckerhoff: as the editor and primary author of the firm’s compelling pharmaceutical patents blog, is as up to date on life sciences market trends and developments as anyone. Post-grant proceedings are the domain of George Quillin, who works primarily in the mechanical and electromechanical areas. He is well known for having represented Greene’s Energy in Oil States Energy Services v Greene’s Energy Group. Multiple parts of the practice got a boost in March 2020 when Eric Sophir joined from Dentons. An electronics expert, Sophir engages in prosecution, counselling, licensing and post-grant activities.

Gardella Grace PA 

Gardella Grace fields an experienced line-up of patent professionals who collectively cover all the bases for innovators as they protect their intangible assets and monetise and enforce their rights. The boutique was established by “post-grant guru” Greg H Gardella, whose “insight into inter partes review strategy as it interplays with litigation strategy is invaluable”. As peers note, “Greg only works with high-quality people”; on his team are PhDs with in-house experience, scientific research prize-winners and crackerjack litigators.

Gibson Dunn & Crutcher LLP

For the toughest litigations, Gibson Dunn can put together tailored strike forces from its national bench of eminent trial lawyers. It can tool up at short notice, too, and is regularly called on to take over representations right before trial where previous counsel are falling short or additional firepower is needed. The DC office’s top man is Brian Buroker, a “workhorse who is smarter than smart and excellent at his craft”. “He has a broad range of litigation experience that makes him a far better advocate.” Gibson Dunn’s litigators can back up any wins – and turn around unfavourable decisions – at the Federal Circuit thanks to the wizardry of Mark Perry, one of the nation’s foremost appellate practitioners.

Goodwin Procter LLP

Goodwin Procter’s DC-based patent group is distinguished by its top-drawer ITC capabilities, appellate prowess and expertise in Hatch-Waxman Act litigation. In the past year or so, it has chalked up key victories on all these fronts. In the ITC, Goodwin represented Shenzhen Absen Optoelectronic and its US distributors in a competitor suit regarding billboard display technology; the team’s adoption of an aggressive stance led to the full withdrawal of the complaint. Forming a swift and decisive SWAT team for Section 337 cases are Mark Davis, Ronald Pabis, Stephen Shahida and Patrick McCarthy. In terms of appellate wins, a big one was secured for Teva in the Supreme Court in a dispute with Helsinn Healthcare concerning whether an invention is subject to the on-sale bar if sold, post-America Invents Act, on a confidential basis; the Supreme Court adhered to the broad reading of the on-sale bar as advocated for by William Jay. Appellate star Jay is “wicked smart, but without the ego” and, “though still young, has argued at the Supreme Court many times”. In the pharmaceutical area, William James has been performing at the highest level and staying the course for clients including Actavis, on whose behalf he earned a District of Delaware finding of invalidity of all claims in Tris Pharma’s patents over ADHD drug Quillivant; he continues to handle this case following its remand by the Federal Circuit for additional fact finding.

Grüneberg and Myers PLLC 

A model of flexibility, speed, cost effectiveness and quality, forward-looking Tysons, Virginia patent boutique Grüneberg and Myers has recorded striking growth of late. With prosecution the bedrock of its practice, the ensemble has been structuring robust protection for a host of global companies across multiple industries. It is not just a filing shop, though; strategic value is packed into every direction it provides on matters such as product clearance. Taking charge is Kirsten A Grüneberg, a chemical, biotech and pharmaceutical expert who provides “quick, straightforward but thorough advice” and “achieves the maximum scope of protection in the most efficient way”. Having started from scratch just two years ago, her team is up to an impressive total of 18 people; Grüneberg has hired astutely, too, selecting individuals with in-house experience, international expertise and technical fluency.

Harrity & Harrity LLP

It is simply amazing what Harrity & Harrity has been able to achieve in the patent space by ; applying a carefully thought-out lean manufacturing style system to file vast numbers of patents while maintaining quality of the highest order. Clever use of automation and a uniform writing style play into its efficiency, while a rigorous second-attorney review system helps to set the quality bar high. The compact boutique has worked other magic, too: its dedicated patent analytics group, headed by Rocky Berndsen, has been delving into all sorts of statistics to bring a unique level of industry insight to clients. None of this has gone unnoticed by competitors: “It is growing faster than any similarly sized peer and runs an impressive recruiting programme that precisely identifies people who will thrive in its system. The efficiency tools it has invested in are also excellent. Harrity & Harrity just gets prosecution and patents.” From a client perspective, its “reasonable pricing and outstanding customer service” are major plus points, as is its nimbleness: “When an emergency project needs to be completed quickly and done right, it is the only firm to turn to.” Another feather in the outfit’s cap is its admirable proactivity with respect to diversity in the IP profession. In 2019 it launched the Harrity Minority Firm Incubator, which trains attorneys from minority backgrounds in prep and pros and law firm management; at the end of the four-year programme, those schooled under it will establish their own patent boutiques. The genius architects of all this success are John Harrity, Paul Harrity and Paul Gurzo.

Jones Robb PLLC 

When it comes to prosecution, innovators are looking for controlled costs and increasingly seeking out specialists. “The people to call when you need to navigate round tough obstacles at the USPTO,” Jones Robb’s prosecution maestros are “closers who can pick up a seemingly doomed patent application and get an allowance”. Prized for the high-calibre expertise they offer, alongside their personalised service and cost effectiveness, founding partners Susanne T Jones and Kevin D Robb are in hot demand. Jones boasts “exceptional attention to detail” and applies a gimlet eye when monitoring clients’ competitors. “Kevin is someone you can rely on for his strategic judgement and candid advice.” He also has “a great network of international associates to coordinate foreign filings”. Also recommended is Elizabeth Burke, who has a flair for developing commercially meaningful and easily monetisable portfolios. In terms of technical or industry orientation, Jones is centred on biomedical, electro-mechanical and mechanical engineering; Robb’s focus is telecommunications; and Burke’s practice emphasises medical devices.

King & Spalding LLP

New to the DC Metro Area rankings and the US national litigation listings this year, King & Spalding has built up a head of steam in patent practice at both a micro and macro level. The arrival of PTAB doyenne Lori Gordon in 2018 placed the side firmly on the DC map; while the additions of former Cooley lawyer Chris Campbell and erstwhile Mayer Brown partner Stephen Baskin in 2019 significantly strengthened its trial bench. All three are engaged in dynamic cases of commercial significance for the parties involved. “Creative and strategically smart”, Gordon is representing Cisco Systems in a nuanced PTAB action against Arista Networks that has had many twists and turns. Campbell has been putting his nearly three decades of experience to good use defending DR Burton in a suit filed by Trudell asserting patents involving respiratory therapy medical devices; with the ability to sell its flagship product on the line, this is a must-win for DR Burton. In defending Delta Air Lines in an NPE suit, Baskin has stolen a march with his hard-work-upfront approach.

Kirkland & Ellis LLP 

A card-carrying member of the national patent litigation elite, Kirkland & Ellis “continues to be tapped by technology companies for the most significant cases” and is “a lock for the gold tier”. Two stars in its constellation are DC trial supremoes Gregg LoCascio and Edward Donovan, both of whom occupy individual top spots. “Gregg is a stellar performer with an even-keeled personality and highly intelligent approach to building his cases.” One of his most decisive recent victories came for Kapsch TrafficCom against Neology in a suit relating to the ISO 18000-6C standard for radio-frequency identification communication – a multi-layered dispute requiring a fine-tuned cross-forum strategy, which LoCascio put together on his way to proving five out of six Neology patents in suit invalid and forcing the abandonment of the sixth. Donovan, meanwhile, recently linked up with New York’s Greg Arovas (also solid IAM Patent 1000 gold) to represent Dollar Shave Club in patent litigation brought by Gillette regarding razorblade coatings. Also with him on this was Christopher Mizzo, who debuts in the rankings this year. Mizzo is an experienced first-chair in his own right and a savvy post-grant practitioner. Special weapons on the DC roster include John O’Quinn and Paul Brinkman – the former an appellate high flier and the latter an ITC expert. “O’Quinn is outstanding as both an oral advocate and brief writer, and is a gentleman you can trust with your life.” Brinkman has an exceptional winning record at the ITC.

Latham & Watkins LLP

Already a first-class patent litigation firm, Latham & Watkins is only getting stronger: in January 2020 it recruited Adam Perlman from Williams & Connolly, getting an “outstanding and detail-oriented strategist” and “deeply creative thinker” in the process. He will fit in well with this “extremely collaborative group of trial lawyers”, which includes gold-tier triumvirate Matthew Moore, Maximilian Grant and Michael Morin, each of whom garners enthusiastic commendations from the market. Moore is cited as a “great leader”; Grant as a “super-high-energy, focused and committed lawyer”; and Morin as a “down-to-earth and likeable guy in court who is brilliant at simplifying complex technical material”. The depth of the bench here is something to behold: “Awesome first-chair Tara Elliott responds to the market intelligently and has expanded her practice beyond just patent litigation and into data privacy and cybersecurity.” “Calm, poised and wise,” Bert Reiser continues to be “master of all things ITC”. So too Jamie Underwood, who assiduously stays on the cutting edge of ITC trends and developments. Robert Steinberg has developed Latham’s post-grant practice in impressive ways, while David Frazier is spearheading important campaigns in the life sciences, alongside Morin and now Perlman. Lawrence Gotts litigates assuredly across all categories of IP rights and in all forums, making him ready for just about anything. With respect to work highlights, Grant, Morin and Elliott achieved a notable trial victory defending Adobe against allegations made by TecSec, having taken over the case just four months prior to trial; and Moore, Reiser and Steinberg mounted an aggressive challenge to Intellectual Ventures to score an ITC trial win on behalf of Honda. Leading technology companies trust Latham when the chips are down.

Mayer Brown

One of Mayer Brown’s key selling points is its strength in ITC patent litigation, though it is important to stress just how well rounded the practice is: the advocates here are fleet of foot in any contentious forum. Much credit for the firm’s enduring presence in high-exposure cases must go to Jamie Beaber, whose industry and tirelessness bring about success time and again. In his biggest recent case, he has been representing Japanese technology entity Maxell as plaintiff against Apple, alleging infringement of 10 patents directed to location sharing, navigation and video calling, among other smartphone and tablet technologies. With him on this is luminary Alan Grimaldi, a strategic litigation pathfinder with decades of experience. Beaber knows the ITC intimately, though the top forum specialist is Gary Hnath. “Gary is a fantastic litigator who fights hard on the substance without getting distracted by side quests. Highly efficient in this way, he avoids unnecessary expenditure for clients.” He is a repository of trust for Chinese entities such as Ninestar, for which he scored a major ITC victory preventing an attempt by Canon to restrict competition in the secondary market for toner cartridges.

McDermott Will & Emery

It is a mark of the sophistication of McDermott Will & Emery that the firm is sought out to take instructions on complex matters drawing on multiple practice groups; technology companies are seeking holistic business support as they innovate and the firm supplies this in spades. The patent litigators on deck buy into this and are collaborative lawyers who always see the bigger commercial picture and allow it to drive litigation and trial tactics. Superlative in this way are Paul Schoenhard and Nicole Jantzi, “two of the smartest and most effective IP lawyers on the market”. “Paul, in particular, is something of a savant when it comes to strategic thinking on patent and other matters.” Both are entering the prime of their careers in style – Jantzi, for example, as leader of the firm’s global IP practice – and form a dynamic double act that always has a positive impact. As an example, check out their work for Contour IP Holding as patent owner in an inter partes review against GoPro, which failed to establish the unpatentability of any challenged claim – a result that bullet-proofed Contour’s patents. ITC combatants, meanwhile, take heart in the presence of Jay Reiziss, who has insider knowledge of the venue, having worked in the Office of General Counsel, the chairman’s office and the Office of Unfair Import Investigations. There is something on offer for everyone at McDermott: standing sentry for pharmaceutical companies is Thomas Steindler, a veteran lead counsel deployed by the likes of Novartis to defend accusations of patent infringement. Manning the prosecution desk, Michael Fogarty is a rock for Panasonic, for which he manages hundreds of patents a year.

Morgan Lewis & Bockius LLP

Morgan Lewis has cemented its status as a prime destination for ITC patent litigation. Its upwards trajectory has been steep, but this has never put it in a bind; with a large headcount and experts in every esoteric area of science, the IP group is superbly equipped – and it enjoys staunch backing from the global full-service firm’s other departments. Making it all count, the team recently went out to bat for One World Technologies, winning three inter partes reviews against the Chamberlain Group that enabled it to continue importing its products into the United States; there is a complicated ITC backstory to this case, involving product redesigns and Court of International Trade actions, which also eventually turned out well, with a recent ruling from the chief administrative law judge that the redesigned products violate no ITC orders. Once again assembling a powerful cross-office team for a sprawling suit, Morgan Lewis is also acting for General Electric against patent infringement and false advertising allegations brought by Lighting Science Group in district courts and, on highly expedited schedules, at the ITC. At the forefront of both matters is Eric Namrow. He knows the judges, the commissioners and the ITC staff – and how unforgiving the forum can be – and makes all necessary adjustments to secure the results that he and his clients need. He is ideally placed to handle any contingency in enterprise-threatening cases. Morgan Lewis is a premier destination not just for litigation, but for non-contentious patent work, too. Flying the flag of the prosecution group in DC are Hosang Lee and Robert Smyth, who respectively focus on high-tech matters and life sciences. Lee has close ties to the Korean market; Smyth also has international horizons and manages a worldwide portfolio for Merck & Co.

Morris Manning & Martin LLP

Morris Manning & Martin is a discerning choice of patent counsel for biotech companies and universities in particular. The DC IP group, spearheaded by Ping Wang, has cracked the recipe for successful patenting at the USPTO and, crucially, understands that patent rights have business impact only if they can be successfully enforced and commercialised. Creating commercially valuable portfolios and getting clients an outstanding rate of return on their investment in intellectual property is a trick that medical doctor Wang and collaborator Michael Ye have mastered to the full. Demonstrating impressive range, Wang handles entire IP portfolios for clients alongside corporate matters and FDA regulatory strategies on an international basis. Ye has enjoyed great success of late, obtaining patent protection for Akonni Biosystems’ recently FDA-approved molecular diagnostics technology, among other things.


Perennially a top filer, Oblon has deep institutional USPTO experience, such that it can effortlessly dispatch high volumes of routine or foreign origin prosecution alongside more strategically driven patenting activities. While the firm is proficient in all technical fields and scientific disciplines, the chemical group is one of its strongest, with multiple members earning IAM Patent 1000 stripes, including Vincent Shier, Daniel Pereira, Marina Miller and Derek Mason. Shier still prosecutes, but in recent years has proven himself particularly adept in post-grant proceedings; complex biopharmaceutical work is in genetics PhD Pereira’s wheelhouse; molecular biology and biochemistry PhD Miller attentively sees to the prosecution, portfolio, post-grant and diligence needs of her loyal client base; while organic chemistry doctor Mason specialises in IP transactions. The electrical and mechanical practices are likewise robust, thanks to the direction of managing partner Philippe Signore, whose exposure to all facets of patent practice grants him a 30,000-foot view of the patent landscape; and the contribution of Todd Baker, who carries on a 45-year Oblon tradition of delivering prosecution excellence to Toyota Motor Corporation. Baker, it should also be noted, serves as chair of the post-grant practice. It is perhaps in litigation that Oblon’s practice has advanced most significantly of late. Garnering special praise this year, Eric Schweibenz has been on his grind at the ITC, providing sterling representation in some heavy-duty cases. “Eric is a passionate advocate for his clients, who fights hard but smart. He has a great analytical mind and a keen eye for detail, and is extremely knowledgeable about the ITC. All round, he’s a great lawyer to have in your corner.” He is building a remarkably successful litigation practice and recently scored a final determination finding no violation of Section 337 on behalf of Aisin Seiki and its customers Toyota and Honda against Intellectual Ventures II, which sought an exclusion order that, if granted, would have seriously disrupted Aisin Seiki’s business. Also packing a punch in litigation is polished trial presenter Alexander Hadjis.

Paul Hastings LLP

Paul Hastings has established itself as one of the premier patent litigation players in the United States. Positioned to handle bet-the-company suits in any forum, it is a firm you can stick with from start to finish. A key thread in its recent narrative is continued success before the PTAB and the Federal Circuit; global IP vice chair Naveen Modi has been on a rocket ride recently, scoring no fewer than nine Federal Circuit victories for industry leaders in under 12 months. “Naveen is a top strategist, extremely articulate presenter and all-round thought leader.” He has built out a formidable post-grant practice in the past six years with the support of Joseph Palys, a former supervising examiner at the USPTO who excels at ensuring that post-grant arguments are cogent from a technical standpoint. Their efforts have considerably amped up the wider litigation practice, manned in DC by Allan Soobert, Blair Jacobs and Jeffrey Pade. Modi is teaming up with them all, as well as West Coast heavy hitter Yar Chaikovsky and others, on multiple key cases for Samsung Electronics. Soobert and Jacobs have a lot in common: both are trial veterans who know how large, multi-patent, multi-forum matters play out in the end game; from day one of a case, they think constantly about how ultimately to present it to judge and jury. Pade is an authority when it comes to trade secret litigation.

Paul Weiss Rifkind Wharton & Garrison LLP

Some of the most innovative companies in the world put Paul Weiss in their corner when mind-bendingly complex or high-stakes patent infringement battles loom – its track record inspires confidence when only a win will do. The firm’s success is derived from the superior trial skills of individuals such as David Ball and Kenneth Gallo, and the unmatched post-grant expertise of Steven Baughman. When all three come together, great things happen. The trio are currently defending SAP with respect to its flagship product HANA in an action brought by business analytics provider Teradata alleging trade secret misappropriation, copyright infringement and antitrust violations – a good example of the sort of multilayered matters they tackle on the daily. Ball is an agile litigator whose recent workload has included pharmaceutical inter partes reviews, biosimilar cases and shootouts between electronics companies. Gallo serves as lead adviser to oncology market kingpin Genentech. Baughman went 47-0 in final written decisions on behalf of petitioners in the first 4.5 years of PTAB trials.

Perkins Coie LLP

Among general practices in the United States, few have as diverse and integrated a patent group as Perkins Coie. The firm is comfortable maintaining its prosecution offering, which sits neatly alongside its transactional practice in a structure that fosters a commercially focused approach to patenting. In litigation, meanwhile, Perkins Coie continues to fly high with respect to volume of instructions and results. Crucial to the success of the ensemble in biotech and pharmaceutical cases is Shannon Bloodworth, a trial lawyer who “really knows how to command the attention of a judge”. Her work for Mylan Pharmaceuticals stands out – particularly her precedent-setting PTAB and Federal Circuit victories against Allegan and the St Regis Mohawk Tribe involving tribal sovereign immunity and patents covering billion-dollar eye medication Restasis.

Pillsbury Winthrop Shaw Pittman LLP

Under the inspirational leadership of top patent strategist Jack Barufka, Pillsbury’s rise in the patent area has been thoughtful and steady; it has not suffered significant lows like some competitors and each year, without losing people, it astutely adds good laterals and gains new clients – all of which is assuring to technology companies. In addition, the lawyers here diligently stay on the cutting edge of technological development and, going the extra mile, will monitor relevant new tech spaces so they are primed and ready when clients want to make moves. Setting a fine example in terms of this proactivity is IAM Patent 1000 debutant Ngai Zhang, who is knowledgeable about everything happening in the blockchain and AI spaces, among others. “Ngai thinks laterally, not linearly, and works tirelessly to create strategic patents that fully capture the value of ideas and are aligned with business interests. He and his team do top-quality work in a timely manner and aren’t fazed by aggressive deadlines. Importantly, Ngai is open and honest about bandwidth and never bites off more than he can chew; lawyers elsewhere say they can handle additional work despite not finishing what they have already been assigned.” Moving over to litigation, the firm has grown significantly in the life sciences. Keeto Sabharwal enjoys a steady diet of abbreviated new drug application (ANDA) cases, but also artfully crosses technical divides to apply his whetted trial skills in high-tech spaces. The dynamism of the ITC as a patent litigation venue has afforded further opportunities for practice development. Kecia Reynolds holds the reins of the Section 337 practice. By combining the skillsets of its prosecution and litigation teams, Pillsbury has unlocked the secret to success at the PTAB, too; a jack of all patent trades, Patrick Doody makes an effective captain of the USPTO contested proceedings practice. William Atkins continues to burnish his reputation as both a top trial lawyer and PTAB mind.

Rothwell, Figg, Ernst & Manbeck, PC

Rothwell Figg practises patent law at the bleeding edge. Its well-balanced, versatile lawyers see trends emerge first hand, whether in litigation, prosecution or post-grant proceedings; by connecting the dots and intuiting the overarching themes, then feeding that all back into their strategies and advice, they futureproof clients’ patents and business advantage. On the litigation front, Steven Lieberman et al have acknowledged the increasing prominence of trade secret litigation, the growing involvement of litigation funding entities and the emergence of super-trolls, and adjust and manoeuvre accordingly. “One of the best lawyers in DC in any practice, Steve is incredibly smart and thorough – and also lightning-quick on his feet. A genuinely nice person, he is someone you can instantly trust.” A beacon of light for media entities, he spearheads important campaigns for the likes of Fandango Media, for which he recently prevailed at the Federal Circuit to secure an affirmance of a district court decision under Section 101 with respect to three audiovisual content access patents. In this sector, he knows the technology issues and understands the principles that guide clients’ decision making. The life sciences is another bastion of strength for the group, which boasts a pharmaceutical litigation luminary and trailblazer in Anthony Figg. He recently obtained an important victory for Pfizer and Synthon Pharmaceuticals against Teva, with the Federal Circuit affirming a District of Delaware decision invalidating four Teva patents relating to multiple sclerosis treatment methods; this is the sort of win he has achieved routinely throughout his illustrious career. Protean patent professional Danny Huntington calls upon extensive biotech and pharmaceutical experience, too, and deploys his expertise to particularly striking effect at the PTAB where, alongside Figg, he has been representing the Seattle Children’s Research Institute. Joseph Hynds knows how to play the Hatch-Waxman Act litigation game and has been doing so for many years. Like Huntington, he acquits himself with distinction in post-grant settings and is one of the engines behind Rothwell Figg’s leading practice in the area. Moving to the high-tech theatre, Robert Parker has been knocking it out the park of late, at least judging by the superlative feedback he attracts. “While operating as the quarterback, Bob assembles and organises teams which are extremely capable from pre-trial phases of a case all the way through the appeals process. He has a unique ability to get the best out of his people and utilise their various skillsets to further clients’ interests. His advocacy is excellent and he is highly regarded by judges.” Together with Martin Zoltick and Steven Weihrouch, he has been representing Nichia in a series of lawsuits in Texas and California against various parties – including Feit Electric, TCL, Vizio and Lowe’s – and in two arbitration proceedings. Of Zoltick, one peer comments: “Marty brings a level head to litigation and can calm heated situations to pave the way for good business outcomes.” Coming from a mechanical engineering background and skilled in the art of prosecution and litigation, Weihrouch is a trusted adviser to many automotive and manufacturing entities. Sharon Davis is another seasoned litigator and one who can be counted on for resonant performances whatever the technology or forum. She impressed with a recent complete victory for Donuts Inc and Enom in a suit involving complex subject matter eligibility issues.

Sidley Austin LLP

Jeffrey Kushan recently played a key role in one of the biggest-ever patent cases, acting for Amgen and subsidiary Immunex in a suit concerning patents protecting Amgen’s Enbrel product, the world’s fifth best-selling biologic. Following a two-week bench trial, Amgen prevailed in court, prompting a next-day $10 billion rise in its market capitalisation. There is a lot of high-level talent in Sidley’s DC office in addition to Kushan. ITC pro Brian Nester has been leading on a complex case for SK Hynix against Netlist in the ITC, PTAB and Central District of California; while further firepower comes from Supreme Court star Carter Phillips.

Steptoe & Johnson LLP

Steptoe’s prosecution practice has been humming along nicely of late; DC’s Harold Fox and New York’s Ying Li have promoted growth in the life sciences space, with chemist Fox performing flawlessly on the small molecule side and immunologist Li mastering the world of antibodies and biologics. They run a nicely diversified operation serving a mix of long-term, large institutional clients and smaller companies. The Massachusetts Institute of Technology is a good example of the former; Fox serves it as primary IP counsel and is responsible for the protection of various nanotechnologies. For emerging businesses, Fox and Li add value by strategically developing their product lines while navigating regulatory hurdles. ITC litigation is another dynamic part of Steptoe’s IP offering. Pacing the team here is John Caracappa, a rare trial lawyer who knows every detail of his cases. He is currently asserting six patents relating to infotainment systems at the ITC on behalf of Broadcom Corporation, together with patent and unfair competition ace Boyd Cloern.

Sterne, Kessler, Goldstein & Fox PLLC 

Whichever way you cut it, Sterne Kessler’s patent practice is magnificent: the eminent DC boutique is steeped in the art of prosecution, a “market leader in post-grant proceedings” and a force to be reckoned with in hardcore district court, ITC and Federal Circuit patent litigation. There are interesting storylines to dig into in each of these areas when reflecting on the recent past. In litigation, for example, ITC captain Daniel Yonan has handled a remarkable five trials in an 18-month period. Yonan is well past fighting for recognition, clients and cases, and is an established Section 337 leader and multi-forum trial lawyer; he astutely harnesses the firm’s technical horsepower and has a knack for getting clients out of cases quickly and satisfactorily, saving them time, money and potential heartache. Recent highlights include securing a final determination of no violation from the ITC in what was a major business win for Feit Electric against Philips Lighting. Dennies Varughese, who leverages a background in pharmacy and fine-grained understanding of regulatory law in his flourishing pharmaceutical litigation practice, has also had an exciting year. Confident and assertive, but never brash, he digs deep to deliver spirited advocacy that compels decision makers to rule in his favour. He took the lead on an ANDA case for Wockhardt Bio, which sought to launch a generic version of Janssen’s Zytiga drug; following three separate inter partes reviews (one of which was instituted by Sterne Kessler, whose arguments the others relied on), Janssen’s patent was found invalid. Veteran trial lawyer John Christopher Rozendaal has also enjoyed success of late, defending Teva in a Hatch-Waxman suit brought by Warner Chilcott, Qualicaps and Allergan Sales over ulcerative colitis drug Delzicol. Rozendaal co-chairs the trial and appellate group and is prized for his narrative gifts in the courtroom, whatever the technology at issue. With him on the Teva case was Federal Circuit supremo Jon Wright, who co-chairs an increasingly dynamic and appellate practice with Michael Joffre and also co-heads a superlative USPTO trials practice. However, the number-one post-grant superstar in the firm is undoubtedly Eldora Ellison. As a biochemistry and molecular and cell biology PhD, she has the science on lock, though she is chiefly highlighted as an “aggressive and highly persuasive” advocate. Prosecution chair Eric Steffe is also heavily engaged in PTAB work and is partnering with Ellison and biotech pathfinder Jorge Goldstein to advise the University of California Regents with respect to CRISPR gene editing technology. Ellison, Steffe and Goldstein are good examples of the sort of high-level strategists with which founding partner and patent prophet Robert Greene Sterne has always surrounded himself . Others in this mould include “tenacious, high-energy lawyer” Robert Sokohl; distinguished all-rounder Michael Ray; savvy licensing and commercial IP player Michael Lee; and designs authority Tracy-Gene Durkin – all of whom add value thanks to the breadth of their expertise and bird’s-eye view of the patent landscape. Donald Featherstone should be noted, too, as a portfolio manager par excellence with deep international knowledge and a wonderful network of contacts. Joining his colleagues in the IAM Patent 1000 for the first time this year is Richard Coller III, who is brilliant at fast-track fixing portfolios so that they are fighting fit for major enforcement campaigns.

Sughrue Mion PLLC

Venerable IP boutique Sughrue is home to 100 patent attorneys, many with postgraduate science or engineering degrees, and can handle any technology you can throw at it, as well as efficiently managing the largest patent portfolios. Proficient in post-grant proceedings and litigation, the firm is a destination of choice for one-stop shopping. Director of the international department Alan Kasper is the man to call for well-supported analysis and opinions.

Venable LLP

Following its 2018 combination with Fitzpatrick Cella, Venable has made impressive headway in intellectual property. Its patent team is adept in complex litigation, prosecution and transactions, and highly cultivated from a technical and scientific perspective, putting it in pole position to provide the sort of holistic support that Fortune 500s and emerging companies are hungry for. It also draws judiciously on the firm’s top government and regulatory affairs group to help put clients on the surest footing. Zooming in on the prosecution practice, counsellors Brian Klock, Michele Van Patten Frank and Henry Daley play a highly involved strategic role for many prestigious names. The Canon relationship is illustrative of this: patent prosecution and counselling chair Klock has prosecuted patents for the company over many years and represented it in USPTO contested proceedings. Frank provides meaningful support in many ways to Viveve, guiding it on international IP strategy, litigation, patent and trademark prosecution, copyright matters, international distribution and regulatory issues. “Michele is a vital partner who goes above and beyond the brief to provide first-class business support. She values smart planning, puts the focus on quality, communicates clearly and responds rapidly.” Eminent scientist Daley, who makes his debut in the IAM Patent 1000 for 2020, takes point for a large state-wide university system, protecting cutting-edge innovations and supporting spin-offs. In litigation, the past year has seen increased levels of cross-staffing between the legacy Fitzpatrick and Venable sides of the firm, which has worked really well; it’s fair to say there is no type of IP case that Venable cannot handle. Dynamic in the practice, Megan Woodworth knows what motivates clients and what commercial wins look like from their perspective. She and Frank Cimino, a seasoned and tenacious trial lawyer, partner well together on the toughest cases. When these are rerouted through the PTAB, they have the backing of top post-grant mind Justin Oliver. On the deal side, Nora Garrote has been pushing boundaries in the AI arena, particularly at its intersection with the education sector. She is also an expert on data-driven deals. Technology transactions and outsourcing lawyer William Russell regularly assists Baker Hughes with complex matters – a recent one being a strategic supply agreement with a major Eastern European customer for a customised software as a service solution for use in the oil and gas industry.

Weil, Gotshal & Manges LLP 

When technology companies clash with key competitors over patents, they dial up Weil Gotshal – few are as prepared for the meat-grinder of high-stakes patent litigation. Its lean-and-mean group has been incredibly busy of late, hammering out the wins across a broad spectrum of technologies, with DC’s Brian Ferguson right in the middle of it. He is representing GE Aviation as lead counsel in no less than 32 inter partes review petitions arising from GE’s competition with Pratt & Whitney to deliver next-generation fuel-efficient jet engines to the airline industry; so far, 200 claims across 17 patents have been either found invalid by the PTAB or abandoned by Pratt & Whitney. Ferguson is not intimidated by any technology and excels at putting his most persuasive case on paper, as well as delivering it in court.

Williams & Connolly LLP 

The patent team of “legendary litigation firm” Williams & Connolly is at its peak and performing at an elite level in the life sciences. “Brilliant on strategy, its trial lawyers are world-class and smart, ethical individuals who are respected by judges. They aren’t afraid of anything – they just keep moving forwards.” The statesman of the team is Bruce Genderson, a veteran biotech and pharmaceutical litigator for whom civility in the practice means a great deal. “A lot of litigators can be unpleasant or untrustworthy, but the opposite is true of the Williams & Connolly folks,” thanks to the tone set by Genderson. Another celebrated name is David Berl, who has “become exceptional in the past few years” and “taken the firm’s practice to the next level”. “David has an amazing intellect and is creative, appropriately aggressive and technically superb.” Jessamyn Berniker and Thomas Selby are also attracting vociferous praise from the market: “Indefatigable and fantastic under pressure, Jessamyn is a great leader who makes sure everyone knows their role and how it fits in the bigger picture. She is outstanding on detail and just really solid all round.” “Tom is sharp as a tack, but he doesn’t take himself too seriously and is lovely to work with. The people on his teams feel valued and he gives associates meaningful experience, which creates an excellent dynamic. He gets great results in court and is a very effective cross-examiner.” Despite the recent departure of Adam Perlman, the bench here remains deep: co-chair of the patent litigation practice Kevin Hardy stands ready to lead on complex SEP enforcement matters. Adept at running major cases, he knows how to develop compelling trial themes and how to deliver in court. Stanley Fisher has broad horizons as a trial lawyer and litigates with confidence and poise in diverse technical fields, across all areas of intellectual property and in regulatory, antitrust and contract disputes. He and Berl are representing AstraZeneca against AbbVie in two parallel cases regarding the first two Bruton’s Tyrosine Kinase inhibitors ever approved – and designated by the FDA as breakthrough cancer therapies. Jonathan Landy is an authority on domestic and international arbitration.

Wilmer Cutler Pickering Hale and Dorr LLP

Post-grant practice is constantly evolving and, unless you are concentrating, it is easy to fall behind. WilmerHale is – few peers are as attentive to which way the wind is blowing at the PTAB. With a keen instinct for sensing emerging trends, such as greater selectivity in instituting inter partes reviews, David Cavanaugh and Greg Lantier respond quickly and do a wonderful job helping companies get to their destination down paths less taken; the high measure of their success speaks to this. Away from client matters, both are also exercising thought leadership to the benefit of all stakeholders in the market. Closely integrated with the ensemble’s world-beating patent litigation practice, Cavanaugh and Lantier do much to ensure a consistent, joined-up approach across litigation and post-grant, which is proving very productive. Trial lawyer Amy Kreiger Wigmore has reaped dividends from (and fuelled) this coordination in her work for OSI Pharmaceuticals, on whose behalf she filed an inter partes review petition, stayed a district court litigation and then defended the PTAB’s favourable decision to invalidate all claims asserted in the litigation at the Federal Circuit. Wigmore plays a central role within WilmerHale’s superlative pharmaceutical patent litigation offering; as does vastly experienced 37-year team mate William McElwain. The two have represented AbbVie in some of the first suits arising under the Biologics Price Competition and Innovation Act. Appellate and Supreme Court litigation is another of WilmerHale’s marquee practices. Strong leadership here is provided by the redoubtable Seth Waxman, a former solicitor general of the United States.

Winston & Strawn LLP 

“Perennially a top litigation firm”, Winston & Strawn continues to dominate in the pharmaceuticals space. Of late, it has vastly expanded its client base in the area of biosimilars, building on its peerless reputation in Hatch-Waxman Act litigation. Instrumental in this regard, Jovial Wong makes his debut in the IAM Patent 1000 this year. Wong has a background in biomedical and environmental health engineering, but – unlike a lot of technical attorneys – is also an assured trial lawyer. As well as biosimilar litigation, he has a refined skillset in pharmaceutical PTAB practice. He takes his cue from Charles Klein, co-chair of Winston’s IP practice and the litigation captain in DC. High-ranking peers hail him as an “excellent leader” who is “great on strategy and in court”. Collaborative and creative, he keeps an open mind and encourages the free flow of ideas. A dynamic ITC practice, helmed by Thomas Jarvis, is another jewel in Winston’s crown. Jarvis’s strategic counselling role has grown recently as foreign and US companies tap his insight in a rapidly evolving and somewhat unpredictable international trade environment; he keeps his ear to the ground in foreign markets, particularly China. His key collaborators in the practice are top technical mind Steven Anzalone and ITC procedural guru Paul Goulet.

Xsensus LLP

Law firms are under considerable pressure to reduce costs in patent prosecution while maintaining quality and many are struggling to adapt. Xsensus was established as an alternative to more traditionally structured and functioning competitors and, unsurprisingly, it is really taking off: in 2019 – its first full year of operation – it cracked the top 100 for obtaining US patents. Its savvy use of the latest and most appropriate technology tools to drive efficiency goes some way towards explaining this accomplishment. Far from making the service robotic, however, this technology-driven approach has allowed attorneys such as Bradley Lytle and Andrew Harry to focus on relationship building – something they both do well, with easy-going manners but a seriousness about the work. Their interpersonal skills appeal not only to clients, but also to examiners, whom they regularly interview to help increase the prospects of success.

Other recommended experts

James Brady and Stephen Soffen are Blank Rome’s representatives in the IAM Patent 1000 for 2020. Brady’s technical know-how in the chemical arts is as comprehensive as his patent practice; while Soffen is similarly well rounded in the high-technology domain. Aziz Burgy is a seasoned member of Axinn’s first-rate pharmaceutical litigation unit. He demonstrates great agility in cases involving large numbers of patent claims that require multi-pronged, aggressive strategies; his recent defence of Par Pharmaceutical in suits filed by Horizon involving a generic version of the drug Ravicti is a case in point. Morrison & Foerster senior counsel Brian Busey is hailed as “an ITC veteran with deep institutional experience” and a “talented lawyer and substance guy”. A lauded appellate and Supreme Court advocate, Gregory Castanias leads Jones Day’s Federal Circuit practice. Exceptionally responsive and a wonderful relationship builder, Jeffrey Costellia invests time to fully understand the issues that are important to his clients, which allows him to custom-fit his patent portfolio development and management counsel. The Nixon Peabody IP group co-leader and global strategies committee chair has been bringing about growth in DC, where the firm recently hired Evan Langdon, a former Adduci Mastriani & Schaumberg ITC specialist. Michael Dilworth understands the value of patents as business assets first hand, having served as chief IP counsel at specialty chemical company Chemtura. The portfolios he manages are shaped perfectly to meet commercial needs. He is the founder and managing partner of Dilworth IP. New kid on the block Element IP was established at the start of 2020 by partners with many years of experience guiding companies on the protection and enforcement of patent rights. Former Oblon attorney Jacob Doughty is one of them; primarily in the chemical field, he has prosecuted extensively on behalf of US, Japanese and European entities. Erin Dunston joined Panitch Schwarze Belisario & Nadel in March 2020 after a decade spent at Buchanan Ingersoll & Rooney. She is highly adept in PTAB proceedings and litigation and a respected name in the life sciences. Shamita D Etienne-Cummings and David M Tennant anchor White & Case’s DC patent practice. Etienne-Cummings is quick, decisive and business minded in litigation, and a good leader too. In recognition of her outstanding service, she was recently elected to the firm’s eight-member global management team. Tennant can do just about anything in the practice: a true renaissance man, he obtains copper-bottomed patents, negotiates lucrative deals, litigates at the ITC and advocates before PTAB judges. James Heintz and Joseph Lavelle fly the flag of DLA Piper in the DC Metro Area. They easily get to grips with complex electrical and computer technologies and do sterling work in court breaking them down for judges and juries. Helping Mintz to become the force that it is in the life sciences sector is dealmaker Christopher Jeffers. Armed with a PhD in biochemistry and biophysics, and with general counsel experience on his résumé, he never fails to impress in negotiations. A litigation specialist at Bass, Berry & Sims, Michael Kiklis combines in-depth technical understanding with finely honed advocacy skills, making him well suited to inter partes reviews and other PTAB trials, of which he has handled more than 100. “Alex Lasher doesn’t fool around – he dives into and argues the critical issues in a case. He really knows what he is doing in the ITC and is fun to have on the opposite side.” He practises at feared litigation firm Quinn Emanuel. Kevin Laurence is a mastermind when it comes to post-grant proceedings with a level of experience that is hard to beat. The Laurence & Phillips co-founder knows all the details of his cases and is extraordinarily perceptive at a strategic level, too. A former investigative attorney at the Office of Unfair Import Investigations, Christine Lehman has a deep understanding of the ITC’s workings. The ex-Finnegan litigator is now at Reichman Jorgensen, serving as managing partner of the DC office. Polsinelli is lucky to have Angel Lezak, who “provides critical advice on portfolio strategy, company policy, inventor education and C-suite communication” to electronics and software innovators. “A former USPTO examiner, Angel has a granular understanding of the kinds of patent claims that are most likely to be granted. She has a positive attitude and is always a joy to work with.” Christopher Maier and Timothy Maier run a self-titled boutique in Alexandria that is steadily building on its reputation for quality in electrical engineering prosecution, post-grant proceedings and business-complementary counselling. Among their colleagues, Stephen Kunin is often called on to provide expert testimony on patent practice matters, in light of his experience and USPTO insight. Former Oblon partner Robert Mattson recently set up Mattson IP. He’s in his prime as a litigator and making moves at the ITC. Ropes & Gray’s Scott McKeown is among the leading post-grant proceedings experts in the country. With “a big reputation and a lot of representations under his belt”, he is a “measured lawyer who keeps on top of all the latest PTAB developments”. He has achieved numerous wins for Google of late, most recently as petitioner against Spring Ventures: the PTAB found all 16 claims of the challenged patent unpatentable as obvious. A talented life sciences litigator, Kyle Musgrove recently moved from Haynes and Boone to Parker Poe Adams & Bernstein. Head of Alston & Bird’s DC IP litigation group Scott Pivnick is a deft coordinator of multifaceted international patent suits and of joint defence groups in US litigation. Orrick’s Steven Routh has tried many cases and never lets any of his clients down. The American College of Trial Lawyers fellow can be counted on to deliver satisfying business wins. Perry Saidman of Saidman DesignLaw is a trailblazer in the area of design patent protection. Daniel Shanley prosecutes electro-mechanical patents with distinction and applies his astute analytical mind to validity and infringement, freedom-to-operate and other issues. The Hunton Andrews Kurth partner carries out precise, error-free work for Toyota and NICHIA Corporation, among others. Jason M Shapiro is distinguished by the breadth of his proficiency in patent practice. Great at prosecution, post-grant proceedings, litigation and transactions, he knows just what to do no matter what the problem presented to him. The Edell Shapiro & Finnan lawyer has Navy research and in-house patent counsel experience on his résumé and spent a decade at wonderful boutique Rothwell Figg. The number of PTAB proceedings handled by Greenberg Traurig’s Andrew Sommer is nearing triple digits now. The experienced first-chair ex-Winston litigator is at ease with a wide range of complex technologies, from software to pharmaceuticals. Sean Trainor is the top ITC specialist in O’Melveny’s hard-hitting patent litigation practice. He is a top authority on the domestic industry requirement. Jeffrey Wolfson serves as chair of Haynes and Boone’s sophisticated patent prosecution and counselling section. The “on-point, business-minded lawyer” has the magic touch when it comes to keeping clients out of court through risk-sensitive prosecution and portfolio management. His patrons include Nabors Industries; he puts up fortresses around the offshore drilling leader’s technology and conducts IP due diligence on its key deals. William Zimmerman is vastly experienced in pharmaceutical litigation and co-chairs the Knobbe Martens Hatch-Waxman and life sciences groups.

Individuals: litigation

  • David J Ball Jr - Paul Weiss Rifkind Wharton & Garrison LLP
  • David Berl - Williams & Connolly LLP
  • G Brian Busey - Morrison & Foerster LLP
  • Ruffin B Cordell - Fish & Richardson
  • Edward C Donovan - Kirkland & Ellis LLP
  • Alan M Fisch - Fisch Sigler LLP
  • Bruce R Genderson - Williams & Connolly LLP
  • Maximilian A Grant - Latham & Watkins LLP
  • Gary M Hnath - Mayer Brown
  • J Michael Jakes - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Thomas L Jarvis - Winston & Strawn LLP
  • Charles B Klein - Winston & Strawn LLP
  • Steven Lieberman - Rothwell, Figg, Ernst & Manbeck, PC
  • Charles E Lipsey - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Gregg F LoCascio - Kirkland & Ellis LLP
  • Michael McKeon - Fish & Richardson
  • Naveen Modi - Paul Hastings LLP
  • Matthew J Moore - Latham & Watkins LLP
  • Michael A Morin - Latham & Watkins LLP
  • George F Pappas - Covington & Burling LLP
  • Adam L Perlman - Latham & Watkins LLP
  • Carter G Phillips - Sidley Austin LLP
  • Bert C Reiser - Latham & Watkins LLP
  • Matthew M Wolf - Arnold & Porter Kaye Scholer LLP
  • Steven Anzalone - Winston & Strawn LLP
  • William P Atkins - Pillsbury Winthrop Shaw Pittman LLP
  • James R Barney - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Steven Baughman - Paul Weiss Rifkind Wharton & Garrison LLP
  • Jamie B Beaber - Mayer Brown
  • Jessamyn S Berniker - Williams & Connolly LLP
  • Shannon Bloodworth - Perkins Coie LLP
  • Paul F Brinkman - Kirkland & Ellis LLP
  • Smith R Brittingham - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Brian M Buroker - Gibson Dunn & Crutcher LLP
  • John Caracappa - Steptoe & Johnson LLP
  • Cono A Carrano - Akin Gump Strauss Hauer & Feld LLP
  • Gregory A Castanias - Jones Day
  • Christian Chu - Fish & Richardson
  • Frank C Cimino Jr - Venable LLP
  • Joseph V Colaianni - Fish & Richardson
  • Kevin B Collins - Covington & Burling LLP
  • Mark G Davis - Goodwin Procter LLP
  • Sharon Davis - Rothwell, Figg, Ernst & Manbeck, PC
  • Erin M Dunston - Panitch Schwarze Belisario & Nadel LLP
  • Tracy-Gene G Durkin - Sterne, Kessler, Goldstein & Fox PLLC
  • Tara D Elliott - Latham & Watkins LLP
  • Eldora L Ellison - Sterne, Kessler, Goldstein & Fox PLLC
  • Brian E Ferguson - Weil, Gotshal & Manges LLP
  • Stanley Fisher - Williams & Connolly LLP
  • David P Frazier - Latham & Watkins LLP
  • Kenneth Gallo - Paul Weiss Rifkind Wharton & Garrison LLP
  • Lori A Gordon - King & Spalding LLP
  • Lawrence J Gotts - Latham & Watkins LLP
  • Paul Goulet - Winston & Strawn LLP
  • Alexander J Hadjis - Oblon
  • Kevin Hardy - Williams & Connolly LLP
  • Doris Johnson Hines - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Mark L Hogge - Dentons
  • Joseph A Hynds - Rothwell, Figg, Ernst & Manbeck, PC
  • Blair M Jacobs - Paul Hastings LLP
  • William G James II - Goodwin Procter LLP
  • William M Jay - Goodwin Procter LLP
  • Song K Jung - Dentons
  • Lisa Kattan - Baker Botts LLP
  • Robert Katz - Banner Witcoff
  • Jeffrey P Kushan - Sidley Austin LLP
  • Jonathan M Landy - Williams & Connolly LLP
  • Gregory Lantier - Wilmer Cutler Pickering Hale and Dorr LLP
  • William G McElwain - Wilmer Cutler Pickering Hale and Dorr LLP
  • James Monroe - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Eric Namrow - Morgan Lewis & Bockius LLP
  • Brian Nester - Sidley Austin LLP
  • John O'Quinn - Kirkland & Ellis LLP
  • Ronald Pabis - Goodwin Procter LLP
  • Joseph E Palys - Paul Hastings LLP
  • Robert Parker - Rothwell, Figg, Ernst & Manbeck, PC
  • Mark A Perry - Gibson Dunn & Crutcher LLP
  • Richard Rainey - Covington & Burling LLP
  • Jay H Reiziss - McDermott Will & Emery
  • Timothy W Riffe - Fish & Richardson
  • Steven J Routh - Orrick, Herrington & Sutcliffe LLP
  • John Christopher Rozendaal - Sterne, Kessler, Goldstein & Fox PLLC
  • Thomas HL Selby - Williams & Connolly LLP
  • Stephen Shahida - Goodwin Procter LLP
  • Sturgis Sobin - Covington & Burling LLP
  • Allan M Soobert - Paul Hastings LLP
  • Robert Steinberg - Latham & Watkins LLP
  • Thomas P Steindler - McDermott Will & Emery
  • Robert Greene Sterne - Sterne, Kessler, Goldstein & Fox PLLC
  • Einar Stole - Covington & Burling LLP
  • Seth P Waxman - Wilmer Cutler Pickering Hale and Dorr LLP
  • Amy Kreiger Wigmore - Wilmer Cutler Pickering Hale and Dorr LLP
  • Jon E Wright - Sterne, Kessler, Goldstein & Fox PLLC
  • Daniel E Yonan - Sterne, Kessler, Goldstein & Fox PLLC
  • William Zimmerman - Knobbe Martens
  • Stephen Baskin - King & Spalding LLP
  • William Bergmann - BakerHostetler
  • Jeffrey A Berkowitz - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Aziz Burgy - Axinn, Veltrop & Harkrider LLP 
  • Chris Campbell - King & Spalding LLP
  • Alexander Chinoy - Covington & Burling LLP
  • Boyd Cloern - Steptoe & Johnson LLP
  • Ahmed Davis - Fish & Richardson
  • Lauren Degnan - Fish & Richardson
  • Bryan C Diner - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Patrick A Doody - Pillsbury Winthrop Shaw Pittman LLP
  • Shamita D Etienne-Cummings - White & Case LLP 
  • Matthew L Fedowitz - Buchanan Ingersoll & Rooney PC
  • Elizabeth D Ferrill - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael J Flibbert - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • James Heintz - DLA Piper
  • M Andrew Holtman - Akin Gump Strauss Hauer & Feld LLP
  • John R Hutchins - Banner Witcoff
  • Nicole M Jantzi - McDermott Will & Emery
  • Michael E Joffre - Sterne, Kessler, Goldstein & Fox PLLC
  • Michael L Kiklis - Bass, Berry & Sims PLC
  • Alex Lasher - Quinn Emanuel Urquhart & Sullivan LLP
  • Joseph Lavelle - DLA Piper
  • Christine Lehman - Reichman Jorgensen
  • Robert Mattson - Mattson IP
  • Patrick J McCarthy - Goodwin Procter LLP
  • Frederic M Meeker - Banner Witcoff
  • Erik Milch - Cooley LLP
  • F Christopher Mizzo - Kirkland & Ellis LLP
  • Indranil Mukerji - Fish & Richardson
  • C Kyle Musgrove - Parker Poe Adams & Bernstein LLP
  • Jeffrey A Pade - Paul Hastings LLP
  • Luke K Pedersen - Baker Botts LLP
  • Frank Pietrantonio - Cooley LLP
  • Scott J Pivnick - Alston & Bird LLP
  • Kecia J Reynolds - Pillsbury Winthrop Shaw Pittman LLP
  • Barbara Rudolph - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • H Keeto Sabharwal - Pillsbury Winthrop Shaw Pittman LLP
  • Paul Schoenhard - McDermott Will & Emery
  • Stephen T Schreiner - Carmichael IP PLLC
  • Eric W Schweibenz - Oblon
  • Christopher N Sipes - Covington & Burling LLP
  • S Lloyd Smith - Buchanan Ingersoll & Rooney PC
  • Robert E Sokohl - Sterne, Kessler, Goldstein & Fox PLLC
  • Andrew Sommer - Greenberg Traurig LLP
  • D Sean Trainor - O’Melveny & Myers LLP
  • Jamie Underwood - Latham & Watkins LLP
  • Dennies Varughese - Sterne, Kessler, Goldstein & Fox PLLC
  • David Vondle - Akin Gump Strauss Hauer & Feld LLP
  • T Cy Walker - BakerHostetler
  • Steven Weihrouch - Rothwell, Figg, Ernst & Manbeck, PC
  • Jovial Wong - Winston & Strawn LLP
  • Megan S Woodworth - Venable LLP
  • Qingyu Yin - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Martin M Zoltick - Rothwell, Figg, Ernst & Manbeck, PC

Individuals: prosecution

  • Erika Harmon Arner - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Les Bookoff - Bookoff McAndrews PLLC
  • Courtenay Brinckerhoff - Foley & Lardner LLP
  • David L Cavanaugh - Wilmer Cutler Pickering Hale and Dorr LLP
  • Tracy-Gene G Durkin - Sterne, Kessler, Goldstein & Fox PLLC
  • Greg H Gardella - Gardella Grace PA 
  • Jorge Goldstein - Sterne, Kessler, Goldstein & Fox PLLC
  • John F Hayden - Fish & Richardson
  • R Danny Huntington - Rothwell, Figg, Ernst & Manbeck, PC
  • Thomas L Irving - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Song K Jung - Dentons
  • Robert Katz - Banner Witcoff
  • Michael Q Lee - Sterne, Kessler, Goldstein & Fox PLLC
  • David R Marsh - Arnold & Porter Kaye Scholer LLP
  • Roland G McAndrews - Bookoff McAndrews PLLC
  • Scott A McKeown - Ropes & Gray LLP
  • Mercedes K Meyer - Faegre Drinker Biddle & Reath LLP
  • W Karl Renner - Fish & Richardson
  • Michael Sartori - Baker Botts LLP
  • Mark D Sweet - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Ping Wang - Morris Manning & Martin LLP
  • Christopher Agrawal - Bookoff McAndrews PLLC
  • Hussein Akhavannik - BakerHostetler
  • W Todd Baker - Oblon
  • Jack Barufka - Pillsbury Winthrop Shaw Pittman LLP
  • James W Brady Jr - Blank Rome LLP
  • Martin A Bruehs - Dentons
  • Adriana L Burgy - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Elizabeth Burke - Jones Robb PLLC 
  • James T Carmichael - Carmichael IP PLLC
  • Richard D Coller III - Sterne, Kessler, Goldstein & Fox PLLC
  • Jeffrey L Costellia - Nixon Peabody LLP
  • Henry J Daley - Venable LLP
  • Ross A Dannenberg - Banner Witcoff
  • Michael Dilworth - Dilworth IP
  • Jacob A Doughty - Element IP, PLC
  • Donald J Featherstone - Sterne, Kessler, Goldstein & Fox PLLC
  • Matthew L Fedowitz - Buchanan Ingersoll & Rooney PC
  • Elizabeth D Ferrill - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Thomas Fiala - Fiala & Weaver PLLC 
  • Michael E Fogarty - McDermott Will & Emery
  • Harold H Fox - Steptoe & Johnson LLP
  • Michele Van Patten Frank - Venable LLP
  • C Gregory Gramenopoulos - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Kirsten A Grüneberg - Grüneberg and Myers PLLC 
  • Paul Gurzo - Harrity & Harrity LLP
  • Robert L Hails Jr - BakerHostetler
  • John Harrity - Harrity & Harrity LLP
  • Paul Harrity - Harrity & Harrity LLP
  • Andrew Harry - Xsensus LLP
  • David L Holt - Fish & Richardson
  • Kirsten Johnson - Bookoff McAndrews PLLC
  • Susanne T Jones - Jones Robb PLLC 
  • David EA Jordan - Fish & Richardson
  • Patrick C Keane - Buchanan Ingersoll & Rooney PC
  • Brian L Klock - Venable LLP
  • Mark R Kresloff - Dentons
  • Phyllis K Kristal - Fish & Richardson
  • Stephen G Kunin - Maier & Maier PLLC
  • Kevin B Laurence - Laurence & Phillips IP Law
  • Dale Lazar - Sughrue Mion PLLC
  • Hosang Lee - Morgan Lewis & Bockius LLP
  • Angel Lezak - Polsinelli PC
  • Bradley Lytle - Xsensus LLP
  • Stephen B Maebius - Foley & Lardner LLP
  • Christopher Maier - Maier & Maier PLLC
  • Timothy J Maier - Maier & Maier PLLC
  • Frederic M Meeker - Banner Witcoff
  • Dinesh N Melwani - Bookoff McAndrews PLLC
  • Erik Milch - Cooley LLP
  • Marina I Miller - Oblon
  • Darrell G Mottley - Banner Witcoff
  • Robert G Mukai - Buchanan Ingersoll & Rooney PC
  • Justin J Oliver - Venable LLP
  • Luke K Pedersen - Baker Botts LLP
  • Daniel J Pereira - Oblon
  • George E Quillin - Foley & Lardner LLP
  • Timothy W Riffe - Fish & Richardson
  • Kevin D Robb - Jones Robb PLLC 
  • William C Rowland - Buchanan Ingersoll & Rooney PC
  • Thomas Rozylowicz - Fish & Richardson
  • Daniel G Shanley - Hunton Andrews Kurth LLP
  • Jason M Shapiro - Edell Shapiro & Finnan LLC 
  • Kenneth J Sheehan - BakerHostetler
  • Vincent K Shier - Oblon
  • Philippe Signore - Oblon
  • Michele Simkin - Foley & Lardner LLP
  • Robert Smyth - Morgan Lewis & Bockius LLP
  • Stephen A Soffen - Blank Rome LLP
  • Robert E Sokohl - Sterne, Kessler, Goldstein & Fox PLLC
  • Eric Sophir - Foley & Lardner LLP
  • Eric K Steffe - Sterne, Kessler, Goldstein & Fox PLLC
  • C Scott Talbot - Cooley LLP
  • David M Tennant - White & Case LLP 
  • Michael Tuscan - Cooley LLP
  • Todd R Walters - Buchanan Ingersoll & Rooney PC
  • Jeffrey S Weaver - Fiala & Weaver PLLC 
  • Steven Weihrouch - Rothwell, Figg, Ernst & Manbeck, PC
  • Charles F Wieland III - Buchanan Ingersoll & Rooney PC
  • Jeffrey A Wolfson - Haynes and Boone LLP
  • Yanbin Xu - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael X Ye - Morris Manning & Martin LLP
  • Ngai Zhang - Pillsbury Winthrop Shaw Pittman LLP
  • Martin M Zoltick - Rothwell, Figg, Ernst & Manbeck, PC

Individuals: transactions

  • Jack Barufka - Pillsbury Winthrop Shaw Pittman LLP
  • David L Cavanaugh - Wilmer Cutler Pickering Hale and Dorr LLP
  • Jeffrey L Costellia - Nixon Peabody LLP
  • Nora E Garrote - Venable LLP
  • Jorge Goldstein - Sterne, Kessler, Goldstein & Fox PLLC
  • Susan E Hendrickson - Arnold & Porter Kaye Scholer LLP
  • John Hurvitz - Covington & Burling LLP
  • Stuart Irvin - Covington & Burling LLP
  • Christopher E Jeffers - Mintz
  • Song K Jung - Dentons
  • D Brian Kacedon - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Patrick C Keane - Buchanan Ingersoll & Rooney PC
  • Michael Q Lee - Sterne, Kessler, Goldstein & Fox PLLC
  • Stephen B Maebius - Foley & Lardner LLP
  • J Derek Mason - Oblon
  • John C Paul - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Luke K Pedersen - Baker Botts LLP
  • William H Pratt - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Michael B Ray - Sterne, Kessler, Goldstein & Fox PLLC
  • William T Russell - Venable LLP
  • Adam Ruttenberg - Cooley LLP
  • Jason M Shapiro - Edell Shapiro & Finnan LLC 
  • Robert E Sokohl - Sterne, Kessler, Goldstein & Fox PLLC
  • Robert Greene Sterne - Sterne, Kessler, Goldstein & Fox PLLC
  • David M Tennant - White & Case LLP 
  • Michael Tuscan - Cooley LLP
  • Ping Wang - Morris Manning & Martin LLP


  • E Anthony Figg - Rothwell, Figg, Ernst & Manbeck, PC
  • Alan M Grimaldi - Mayer Brown
  • Perry Saidman - Saidman DesignLaw Group
  • Robert L Stoll - Faegre Drinker Biddle & Reath LLP